Principales collaborations
NATIONALES
- Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), INSERM U1048, Toulouse
- INSERM U1034, Bordeaux
- INSERM U1011 et LIRIC UMR995, Lille
- EA 3801 "Hémostase et remodelage vasculaire post-ischémie (HERVI)", Reims
- Groupe Hospitalier Pitié Salpêtrière, Paris
- Unité EGEAL, Institut LaSalle, Beauvais
- Hôpital Ambroise Paré, Boulogne-Billancourt
- CHU Angers, Angers
- Centre de Recherche des Cordeliers, Paris
INTERNATIONALES
- Institute of Pharmacy, Biosciences, Martin Luther University Halle-Wittenberg, Halle, Allemagne
- University of Basilicata, Potenza, Italie
- New York University School of Medicine, New York, USA
- M.M. Shemyakin &Yu.A. Ovchinnikov, Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscou, Russie
- Faculty of Biology Medicine and Health, University of Manchester, Manchester, Angleterre
- Faculty of Pharmaceutical Sciences, K.U. Leuven, Belgique
- Department of Clinical Chemistry, Ghent University Hospital, Ghent, Belgique
- Institute for Neuropathology, University of Freiburg, Freiburg, Allemagne
- Heidelberg University, Heidelberg, Allemagne
INDUSTRIES
- Société Soliance, Pomacle-Bazancourt
- Laboratoires Pierre Fabre, Toulouse